GlassScriptPhysician profile
Mary K Johnson
NPI 1720309750
$4,505.09
in general payments reported to CMS, 2019-2025
37 companies · $642 in 2025
The $642 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $401 · 2020: $426 · 2021: $700 · 2022: $854 · 2023: $497 · 2024: $984 · 2025: $642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,029 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,029.42 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $698.60 | 2019-2025 | |
| Novo Nordisk INC | $323.02 | 2020-2025 | Wegovy |
| Daiichi Sankyo INC. | $319.27 | 2019-2025 | Injectafer |
| Exeltis, USA INC. | $291.68 | 2019-2025 | Slynd |
| Astellas Pharma US INC | $271.63 | 2023-2024 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $240.19 | 2023-2025 | Myfembree |
| Shield Therapeutics INC | $233.79 | 2023-2025 | Accrufer |
| Hologic Sales and Service, LLC | $202.31 | 2019-2025 | Novasure, Acessa Provu System, Myosure Tissue Removal Device |
| Biogen, INC. | $195.62 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $185.98 | 2020-2025 | |
| Amgen INC. | $179.64 | 2019-2021 | |
| Boston Scientific Corporation | $137.45 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $125.46 | 2022-2025 | |
| Pfizer INC. | $114.14 | 2019-2025 | |
| Myovant Sciences INC. | $101.57 | 2021-2022 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.